Reckitt Benckiser Group plc (RBGLY) Stock Price & Analysis
Reckitt Benckiser Group plc (RBGLY) — price $13.15 (+0.77%), as of the Oct 2, 2026 trading session; market cap $41.8B. Expected results Mar 3, 2027.
Educational signal · not a buy or sell recommendation · How to read this
Reckitt Benckiser Group plc · RBGLY · Consumer Defensive · Household & Personal Products
Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen,…
Price as of Oct 2, 2026
Key Statistics
No publishable V2 score is available for this stock yet.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $13.15 | |
| Change on the day | +0.77% | |
| 52-week range | $12.02 – $22.15 | |
| Market capitalisation | $41.8B | |
| Price / earnings (trailing) | 11.04 | |
| Shares traded on the day | 52.3K | |
| Beta (volatility vs the S&P 500) | 0.26 | |
| Dividends per share (last 12 months) | $1.21 | |
| Dividend yield (last 12 months) | 9.21% |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · in line with the recorded estimate
- · Earnings call · management outlook
- · Earnings results · below the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
Management outlook
For the second half, we expect emerging markets to deliver ongoing broad-based growth similar to half 1. In Europe, we expect to return to like-for-like net revenue growth in half 2 with sequential improvement through the half, supported by strong execution and innovation launches as well as planned pricing actions.
Shannon Eisenhardt · Statement from
We, therefore, remain confident in our outlook, and we reiterate our expectation for 2026 to deliver 4% to 5% like-for-like net revenue growth in Core Reckitt as we continue to build a stronger Reckitt and create long-term sustainable value for shareholders.
Kris Licht · Statement from
Statement dates identify the earnings call, not a deadline. Management expectations and provider estimates can change.
Read management statementsOther perspectives
Council score for Reckitt Benckiser Group (RBGLY): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 28, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 9, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 9, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Oct 5, 2026, except a card that shows its own read date.
Watch the RBGLY film — every key number, told as a short cinematic story
~2 min · open the film
What is Reckitt Benckiser Group (RBGLY), and what does it report?
Short answer · as of
Reckitt is not merely a household-products manufacturer. Its portfolio combines cleaning and pest-control brands with pain relief, digestive remedies, sexual wellness and infant nutrition, so reported revenue reflects several distinct forms of recurring consumer demand.
Research dated 2026-09-12.
Reckitt is not merely a household-products manufacturer. Its portfolio combines cleaning and pest-control brands with pain relief, digestive remedies, sexual wellness and infant nutrition, so reported revenue reflects several distinct forms of recurring consumer demand.
The group reports through Hygiene, Health and Nutrition, while RBGLY is an over-the-counter quotation for the United Kingdom parent. Consolidated figures therefore measure the broad brand portfolio rather than a narrow product franchise or a domestic American operator.
What do the latest results show for Reckitt Benckiser Group (RBGLY)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $8.53B. Against analyst estimates the company has EPS beat 3 of 8 reports.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $8.52B Jul 29, 2026
- Latest report · revenue estimate
- $8.25B Jul 29, 2026
- Latest report · revenue vs estimate
- Above estimate Jul 29, 2026
- Latest report · EPS vs estimate
- Below estimate Jul 29, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Jul 29, 2026 | $8.52B | $8.25B | $0.2687 | $0.3807 |
| Mar 5, 2026 | $9.90B | $9.90B | $0.4994 | $0.4994 |
| Jul 24, 2025 | $9.45B | $9.56B | $0.3970 | $0.4610 |
| Mar 6, 2025 | $9.03B | $9.10B | $0.5050 | $0.4082 |
Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $8.53B | $867M | $0.27 (diluted) |
| Q4 FY2025 | $9.48B | $2.92B | $0.90 (diluted) |
| Q2 FY2025 | $9.22B | $1.27B | $0.37 (diluted) |
| Q4 FY2024 | $9.25B | $375M | $0.11 (diluted) |
What are the financial strengths and risks for Reckitt Benckiser Group (RBGLY)?
Short answer
The distress and quality screens read Altman Z 3.23 · Piotroski F 7. Trailing ratios: ROE 45.3% · ROA 12.7% · current ratio 0.85 · earnings yield 10.2% · free-cash-flow yield 4.7%.
What should you watch next at Reckitt Benckiser Group (RBGLY)?
Short answer · as of
The next earnings report is expected on Mar 3, 2027.
What management is planning
Management expectations, not completed milestones or guarantees. Selected verbatim excerpts; dates follow the transcript provider.
For the second half, we expect emerging markets to deliver ongoing broad-based growth similar to half 1. In Europe, we expect to return to like-for-like net revenue growth in half 2 with sequential improvement through the half, supported by strong execution and innovation launches as well as planned pricing actions.
Shannon Eisenhardt ·
We, therefore, remain confident in our outlook, and we reiterate our expectation for 2026 to deliver 4% to 5% like-for-like net revenue growth in Core Reckitt as we continue to build a stronger Reckitt and create long-term sustainable value for shareholders.
Kris Licht ·
In terms of the cost to deliver the program, we continue to expect it to be around GBP 1 billion and for this to be around GBP 350 million in 2026.
Shannon Eisenhardt ·
And in North America, we expect to deliver a stronger half 2 weighted towards Q4 given the challenging comparative in Q3.
Shannon Eisenhardt ·
What the records here don't tell us
- Detailed statement figures are not shown because their conversion to USD has not been verified.
- No insider Form 4 transaction falls inside the window this page reads.
Checked against the records this page reads, on the dates shown above.
How is Reckitt Benckiser Group scored?
Research dated 2026-09-12.
Unlike a narrowly focused home-care peer, Reckitt combines surface hygiene, laundry care and pest control with consumer health, sexual wellness and infant nutrition. Demand is therefore spread across replenishment, self-care and nutrition occasions, but performance can diverge sharply among categories and regions.
RBGLY also differs from a domestic American consumer-staples listing: it is an over-the-counter quotation for a British parent. Institutional holdings reported through the American filing channel capture only a thin view of ownership and should not be treated as the shareholder base of the entire group.
| Company | Price | Market value | Score |
|---|---|---|---|
| $71.80 Oct 2, 2026 | $29.8B | — Model unavailable | |
| $13.27 Oct 2, 2026 | $42.6B | — Model unavailable | |
| $22.26 Oct 2, 2026 | $49.5B | — Model unavailable | |
| $39.37 Oct 2, 2026 | $43.7B | — Model unavailable | |
| $91.97 Oct 2, 2026 | $33.3B | — 5-pillar · not comparable | |
| $17.20 Oct 2, 2026 | $33.0B | — 5-pillar · not comparable | |
| $94.36 Oct 2, 2026 | $31.3B | — 5-pillar · not comparable | |
| $84.26 Oct 2, 2026 | $67.4B | — 5-pillar · not comparable | |
| $94.31 Oct 2, 2026 | $22.4B | — 5-pillar · not comparable | |
| $59.70 Oct 2, 2026 | $129B | — 5-pillar · not comparable | |
| $61.97 Oct 2, 2026 | $13.0B | — 5-pillar · not comparable | |
| $80.41 Oct 2, 2026 | $9.72B | — 5-pillar · not comparable |
The comparison model is unavailable. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
- Institutional ownership
- 0.0% Period end Jun 30, 2026
- Previous quarter · ownership
- 0.0% Prior to period end Jun 30, 2026
- Reporting holders
- 1 Period end Jun 30, 2026
- Previous quarter · holders
- 1 Prior to period end Jun 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| Paradigm Asset Management Co LLC | 3,200 |
Quarterly filings lag the period end. Holder rows are names in the provider snapshot, not a verified ranking; individual filing dates are not supplied. Related managers may appear separately, so these positions are not summed. Holder snapshot as of Jun 30, 2026.
What has been published about Reckitt Benckiser Group (RBGLY)?
Common Questions About RBGLY (Consumer Defensive)
Research dated 2026-09-12; the answers below are from that research, and the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
What does Reckitt sell besides Dettol and Lysol?
The portfolio includes Finish, Vanish and Air Wick in household care; Nurofen, Gaviscon and Strepsils in consumer health; Durex in sexual wellness; and Enfamil and Nutramigen in nutrition. These brands place Reckitt across Hygiene, Health and Nutrition rather than inside a narrow cleaning category.
What is Reckitt relying on for regional recovery?
Management expects broad emerging-market growth to continue, Europe to improve through execution, innovation and pricing, and North America to strengthen later in the reporting cycle. Progress against those regional claims is the most direct test of the maintained Core Reckitt outlook.
What is the RBGLY stock price today?
The last price recorded on this page for Reckitt Benckiser Group plc (RBGLY) is $13.15, as of the Oct 2, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
Does RBGLY pay a dividend?
Yes. Reckitt Benckiser Group plc (RBGLY) shows a trailing 12-month dividend yield of 9.21%, as of Oct 2, 2026, in the data on this page. Payout ratio and cash-flow coverage decide whether it can last, and past dividends do not guarantee future payments.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are shown with each answer. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (45 figures)
The 45 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
OFFICIAL — 2 facts from SEC filings and earnings calls
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
prod.outlook | Management outlook — call excerpts | Shannon Eisenhardt (Jul 29, 2026): For the second half, we expect emerging markets to deliver ongoing broad-based growth similar to half 1. In Europe, we expect to return to like-for-like net revenue growth in half 2 with sequential improvement through the half, supported by strong execution and innovation launches as well as planned pricing actions. Kris Licht (Jul 29, 2026): We, therefore, remain confident in our outlook, and we reiterate our expectation for 2026 to deliver 4% to 5% like-for-like net revenue growth in Core Reckitt as we continue to build a stronger Reckitt and create long-term sustainable value for shareholders. Shannon Eisenhardt (Jul 29, 2026): In terms of the cost to deliver the program, we continue to expect it to be around GBP 1 billion and for this to be around GBP 350 million in 2026. Shannon Eisenhardt (Jul 29, 2026): And in North America, we expect to deliver a stronger half 2 weighted towards Q4 given the challenging comparative in Q3. | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) — Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | |
id.hq | SEC filing business address | 103-105 Bath Road, Slough, X0, SL1 3UH | OFFICIAL | SEC EDGAR filer business address — The SEC filer business address. Our market-data provider separately lists "Turner House, Slough, BR, SL1 3UH, GB". |
FMP — 34 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $13.15 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-04T13:44:22.229Z. | |
px.change | Change on the day | +0.77% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalisation | $41.8B | FMP | Financial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:00.000Z. Captured from FMP at 2026-10-04T13:44:21.024Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
earn.next | Next earnings date | Mar 3, 2027 | FMP | Financial Modeling Prep (FMP) earnings calendar — The date is our provider's estimate until the company confirms it. | |
id.business_summary | Business description (FMP excerpt) | Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen,… | FMP | Financial Modeling Prep (FMP) company profile — Deterministic excerpt derived from id.description; source and date describe the input fact, not a new provider observation | |
px.change_abs | Change on the day, in dollars | +$0.10 | FMP | Financial Modeling Prep (FMP) · quote | |
px.pe | Price / earnings (trailing) | 11.04 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 52.3K | FMP | Financial Modeling Prep (FMP) · quote | |
px.beta | Beta | 0.26 | FMP | Financial Modeling Prep (FMP) company profile | |
id.ceo | Chief executive | Kris Licht | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it. | |
id.employees | Employees | 38,100 | FMP | Financial Modeling Prep (FMP) company profile | |
fin.q_revenue | Revenue, Q2 FY2026 | $8.53B | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
earn.history.depth.2026-07-29.revenue_actual | Revenue · reported — report date 2026-07-29 | $8.52B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-29.revenue_estimated | Revenue · estimate — report date 2026-07-29 | $8.25B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-29.eps_actual | EPS · reported — report date 2026-07-29 | $0.2687 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-29.eps_estimated | EPS · estimate — report date 2026-07-29 | $0.3807 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-03-05.revenue_actual | Revenue · reported — report date 2026-03-05 | $9.90B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-03-05.revenue_estimated | Revenue · estimate — report date 2026-03-05 | $9.90B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-03-05.eps_actual | EPS · reported — report date 2026-03-05 | $0.4994 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-03-05.eps_estimated | EPS · estimate — report date 2026-03-05 | $0.4994 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-07-24.revenue_actual | Revenue · reported — report date 2025-07-24 | $9.45B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-07-24.revenue_estimated | Revenue · estimate — report date 2025-07-24 | $9.56B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-07-24.eps_actual | EPS · reported — report date 2025-07-24 | $0.3970 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-07-24.eps_estimated | EPS · estimate — report date 2025-07-24 | $0.4610 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-03-06.revenue_actual | Revenue · reported — report date 2025-03-06 | $9.03B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-03-06.revenue_estimated | Revenue · estimate — report date 2025-03-06 | $9.10B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-03-06.eps_actual | EPS · reported — report date 2025-03-06 | $0.5050 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-03-06.eps_estimated | EPS · estimate — report date 2025-03-06 | $0.4082 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
own.institutions.depth.ownership_pct | Institutional ownership | 0.0% | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.ownership_pct_previous_quarter | Previous quarter · ownership | 0.0% | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.institutions.depth.holders | Reporting holders | 1 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.holders_previous_quarter | Previous quarter · holders | 1 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.top_holders.depth.holder_0.shares | Paradigm Asset Management Co LLC — shares in provider snapshot | 3,200 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. |
UNRECORDED — 4 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.range52 | 52-week range | $12.02 – $22.15 | UNRECORDED | Stored company-profile observation — Captured 2026-10-03 | |
earn.history | Reported versus estimated, recent quarters | EPS beat 3 of 8 | UNRECORDED | Stored earnings-history observation — Captured 2026-10-03 | |
fin.scores | Distress and quality screens | Altman Z 3.23 · Piotroski F 7 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-04 · Expired observation | |
fin.ratios | Return and yield ratios (trailing twelve months) | ROE 45.3% · ROA 12.7% · current ratio 0.85 · earnings yield 10.2% · free-cash-flow yield 4.7% | — | UNRECORDED | Stored key metrics — Date unknown |
COMPUTED — 4 facts from our arithmetic, formula restated
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
div.ttm_per_share | Dividends per share, last 12 months (split-adjusted) | $1.21 | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history — Sum of 3 split-adjusted declared dividends with an ex-date in the 365 days to 2026-10-05, per current share. Ex-dates are not payment dates; special dividends are included. Not a declared annual rate. | |
div.ttm_yield | Dividend yield, last 12 months | 9.21% | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history and quote — Split-adjusted dividends with ex-dates in the trailing 365-day window divided by the packet price, on the same current-share basis. Price date follows the quote, latest price bar or packet-build day when unstamped. Not a forecast or declared annual rate. | |
earn.history.depth.2026-07-29.revenue_actual.comparison | Latest report · revenue vs estimate | Above estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported revenue ($8.52B) with the recorded estimate ($8.25B) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
earn.history.depth.2026-07-29.eps_actual.comparison | Latest report · EPS vs estimate | Below estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported EPS ($0.2687) with the recorded estimate ($0.3807) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
OURS — 1 fact from Stock Expert AI's own score and rank
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
gap.statement_currency | Statement currency limitation | Detailed statement figures are not shown because their conversion to USD has not been verified. | OURS | Stock Expert AI currency-basis check |
Fact-family notes
- Earnings-history note. Source series as of 2026-07-29. Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined. Applies to Fact IDs:
earn.history.depth.2026-07-29.revenue_actual,earn.history.depth.2026-07-29.revenue_estimated,earn.history.depth.2026-07-29.revenue_actual.comparison,earn.history.depth.2026-07-29.eps_actual.comparison,earn.history.depth.2026-07-29.eps_actual,earn.history.depth.2026-07-29.eps_estimated,earn.history.depth.2026-03-05.revenue_actual,earn.history.depth.2026-03-05.revenue_estimated,earn.history.depth.2026-03-05.eps_actual,earn.history.depth.2026-03-05.eps_estimated,earn.history.depth.2025-07-24.revenue_actual,earn.history.depth.2025-07-24.revenue_estimated,earn.history.depth.2025-07-24.eps_actual,earn.history.depth.2025-07-24.eps_estimated,earn.history.depth.2025-03-06.revenue_actual,earn.history.depth.2025-03-06.revenue_estimated,earn.history.depth.2025-03-06.eps_actual,earn.history.depth.2025-03-06.eps_estimated.
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources used for research written 2026-09-12
Historical evidence preserved with this analysis. Current figures are listed separately above.
| Evidence | Captured value | Source date | Source type | Source |
|---|---|---|---|---|
| Business description | Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Isaac Reckitt in 1840 and is headquartered in Slough, the United Kingdom. | 2026-09-12 | FMP | Financial Modeling Prep (FMP) company profile |
| Sector / industry (provider taxonomy) | Consumer Defensive / Household & Personal Products | 2026-09-12 | FMP | Financial Modeling Prep (FMP) company profile |
| Ticker / exchange | RBGLY on Other OTC | 2026-09-12 | FMP | Financial Modeling Prep (FMP) company profile |
| Headquarters | 103-105 BATH ROAD, SLOUGH, X0, SL1 3UH Our market-data provider lists "Turner House, Slough, BR, SL1 3UH, GB"; the address on file with the SEC is used here. | 2026-09-12 | OFFICIAL | SEC EDGAR filer business address |
| Employees | Count: 38,100 | 2026-09-12 | FMP | Financial Modeling Prep (FMP) company profile |
| Legal name | RECKITT BENCKISER GROUP PLC Our market-data provider lists the name as "Reckitt Benckiser Group plc"; the filer's own record is used here. | 2026-09-12 | OFFICIAL | SEC EDGAR filer record |
| Institutional ownership (13F) | Holders: 1; Quarter: 2026-06-30; Ownership: 0%; Holders previous quarter: 1; Ownership previous quarter: 0 13F filings are quarterly and lag the quarter end by up to 45 days. | 2026-06-30 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings |
| Largest 1 institutional holders | Captured record · 1 entry
| 2026-06-30 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings |
| Recent SEC filings | Captured record · 2 entries
Forms 10-K, 10-Q, 8-K and Schedule 13D only. Each row links the document the company filed. | 2012-12-19 | OFFICIAL | SEC EDGAR filer submissions |
| Management outlook — dated call excerpts | Captured record · 4 entries
Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | 2026-07-29 | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) |
Data provided for informational purposes only.